News About: Pharm. Industry
Drug advertisement layouts top 1,132 cases in 2010
The Korea Pharmaceutical Manufacturers Association says it screened a total of 1,132 drug advertising layouts last year, showing a 20-percent increase over the previous year.
As a result of the screening, 716 case...
Foreigner named JW Holdings director
Bruno Arco, global marketing specialist, was made the company’s director on Thursday, as a foreigner to head the overseas operation of JW Pharmaceutical Co.
Arco, 49, will oversee the company’s pharmaceutical and m...
Kyungnam to expand its presence in placenta injection market
Kyungnam Pharmaceutical Co. said Thursday that it will go all-out to promote the sales of its placenta injections in the domestic market as the Korean Food and Drug Administration certified the efficacy and safety o...
Drugmakers gear up for sports marketing
Korean pharmaceutical companies are putting more and more efforts into sports marketing in a bold step to raise OTC sales in domestic market. Such moves are likely to be reinforced further as health is the best motto ...
Green Cross develops fourth natural medicine
Green Cross Corp. says its natural drug for the treatment of osteoarthritis drug ‘Shinbaro’ has been recently approved by the Korea Food and Drug Administration.
The company said Shinbaro is Korea’s fourth homegrow...
New anticancer medicine Jevtana designated as orphan drug
Sanofi-aventis Korea said that the Korea Food and Drug Administration has designated Jevtana (cabazitaxel) Injection as an orphan drug.
The company also said Jevtana is expected to be available as a marketed produc...
Ilyang to spur vaccine development
In an effort to develop a variety of vaccines for influenza, food and mouth disease, dengue fever and rabies, Ilyang Pharmaceutical Co, signed a memorandum of understanding with Taiwan based Medigen Biotechnology Corp...
ARB drugs surpass calcium antagonists
The market share of angiotensin-2 receptor blocks (ARB), such as Almetec and Cozzar, has gained momentum, outpacing the former No. 1 drug on the antihypertensive market, Norvasc, by a wide margin.
ARB drugs account...
High-dose Sevikar released
Daiichi Sankyo Korea said Monday it has released a variety of strengths for oral hypertensive Sevikar, which combines two antihypertensive agents in a film-coated tablet.
It contains amlodipine, a calcium channel bl...
Green Cross, aRigen under joint research to combat superbacteria
Green Cross Corp. said Friday that it has signed an exclusive license with aRigen Pharmaceuticals in Japan to develop and commercialize WAP-8294A2 (Lotilibcin), a first-line anti-MRSA (methicillin-resistant Staphyloco...
